1800 202 8726
Drug interactions

Painkillers: Which Ones Are Safe — on Targeted Therapy?

Most common painkillers share the same liver pathway as targeted therapy drugs. Using the wrong one can push your cancer drug to a level that causes toxicity, or pull it low enough that it stops working.

Medically reviewed by Dr. Bharati Devi Gorantla, Medical Oncologist, MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK) · Last reviewed August 2026

  • Shared liver pathway — Ibuprofen, diclofenac and naproxen compete with your targeted therapy for the same liver enzyme.
  • Two risks, not one — NSAIDs also affect the stomach lining and platelet function — both already under strain on many targeted therapies.
  • Paracetamol is the first choice — It has a much lower risk of CYP3A4 interference, but it still has a daily ceiling you should not exceed.
  • Ask before you take anything — This includes over-the-counter medicines, Ayurvedic preparations, and supplements.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Get this explained properly

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Reviewed by a senior medical oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

Paracetamol is the painkiller with the lowest risk of interfering with most targeted therapy drugs. Ibuprofen, diclofenac, naproxen, nimesulide and aspirin taken for pain can disrupt the liver enzyme your targeted therapy depends on, and also raise bleeding risk. Do not take any painkiller without checking with your oncology team first.

Which painkillers should you avoid on targeted therapy?

Avoid ibuprofen, diclofenac, naproxen, nimesulide, and mefenamic acid unless your oncology team has specifically said they are appropriate for you. Aspirin taken for pain — not the small daily dose a cardiologist may have prescribed for your heart — carries the same concern.

Your liver uses a family of enzymes to break down medicines. One of these, called CYP3A4, processes the majority of targeted therapy drugs. Many common painkillers use the same enzyme. When both arrive in the liver at the same time, they compete for processing. The result is unpredictable: your targeted therapy level in the blood may rise, increasing side effects, or fall, reducing how well it is working.

Non-steroidal anti-inflammatory drugs — NSAIDs, which include ibuprofen, diclofenac, naproxen, and nimesulide — add a second problem beyond the enzyme issue. They thin the stomach lining and reduce platelet activity. Several targeted therapies already affect these systems. Combining an NSAID with targeted therapy raises the risk of stomach bleeding independently of the enzyme interaction.

Still unclear?

Send your reports across and a specialist will walk you through what they mean — what is known, what is not, and what the options actually are.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Get a straight answer from a specialist

45 minutes, your reports reviewed, your questions answered in plain language.

Book Free Consultation Call 1800 202 8726

What can you take, and when do you need to call your team?

Paracetamol is the first-choice painkiller for most people on targeted therapy. It does not significantly interact with CYP3A4, and it does not carry the same stomach or platelet risks as NSAIDs. Your team will usually confirm it is appropriate for you.

Paracetamol does have a ceiling. The liver processes it too, and some targeted therapies already place extra demand on the liver. Do not take more than the dose on the packet, do not combine it with other medicines that also contain paracetamol, and tell your team if you are taking it regularly.

Call your team the same day if paracetamol is not controlling your pain, if the pain is new, or if it has clearly changed. Your oncologist can prescribe alternatives that can be used more safely alongside your treatment. Do not add a second painkiller on your own — the interaction risks multiply.

Explore 108 more Side Effects, Emergencies & Daily Living topics

Side Effects - Symptom-Specific Deep Dives

All Side Effects, Emergencies & Daily Living →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Is paracetamol completely safe on targeted therapy?

It carries a much lower risk of interacting with the liver enzymes your targeted therapy depends on, which is why it is the first-choice painkiller for most people on these drugs. It is not without any consideration. Paracetamol is also processed by the liver, and some targeted therapies already put extra strain on it. Staying within the dose on the packet, not combining it with other medicines that also contain paracetamol, and telling your team you are taking it regularly are the three things that keep the risk low.

Why is ibuprofen specifically a problem on targeted therapy?

Ibuprofen causes two problems at once. First, it competes with your targeted therapy for the liver enzyme CYP3A4, which breaks down the majority of targeted therapy drugs. When ibuprofen is in the system alongside your cancer drug, the processing of both changes in ways that are hard to predict. Second, ibuprofen reduces the protective lining of the stomach and affects how platelets work. Many targeted therapies already affect these systems, so combining them raises the risk of stomach bleeding even after a short course.

Can I take aspirin for a headache on targeted therapy?

Not without checking first. Aspirin taken at doses used for pain shares the platelet and stomach lining risks of other NSAIDs, and those risks are meaningful on most targeted therapies. If a cardiologist has prescribed a low daily dose of aspirin for a heart condition, do not stop that without speaking to both your oncologist and cardiologist — stopping it carries its own risk. The concern is specifically with aspirin taken at doses intended for pain or fever.

What about nimesulide or mefenamic acid — they are commonly sold here for pain and fever?

Both are NSAIDs and carry the same concerns as ibuprofen and diclofenac. Nimesulide in particular is widely available in India and is often taken without much thought for headaches and fever. On targeted therapy, it is one of the medicines to avoid without speaking to your team first. If you have been taking either regularly, tell your oncology team at your next appointment — or today if the pain it was managing has returned and you are unsure what to take.

What if my pain is severe and paracetamol is not enough?

Tell your oncology team the same day. Uncontrolled pain is a clinical problem that needs assessment — both because it affects your quality of life and because the cause may need investigating. Your oncologist can prescribe alternatives, including opioid-based pain relief where appropriate, that can be managed more safely alongside your targeted therapy. The answer is not to add an over-the-counter NSAID on top; the answer is a call so your team can decide what is safe for you specifically.

I have been taking ibuprofen regularly without realising. Should I stop immediately?

Call your oncology team today and tell them. Do not stop abruptly without guidance if you have been taking it every day for an ongoing condition — that conversation needs to happen before you change anything. If you have been taking it occasionally, stopping it is reasonable and you should mention it at your next contact. The important thing is not to continue through your next treatment cycle without your oncologist knowing, because the enzyme interaction affects how your body handles every dose of your cancer drug.

Do Ayurvedic or herbal pain remedies interact with targeted therapy?

Some do. Several Ayurvedic preparations and herbal supplements contain compounds that affect the same liver enzymes as many prescribed medicines. Curcumin — the active compound in turmeric taken as a supplement in tablet or capsule form, rather than used in cooking — has known effects on this pathway. Ashwagandha and several other commonly used preparations have also been studied for drug interactions. The difficulty is that interaction data for herbal preparations is far less complete than for pharmaceutical medicines. Tell your oncology team everything you are taking, including tablets, tonics, or preparations from any source. They will not ask you to stop without a reason.

Does it matter which targeted therapy I am on, or does this apply to all of them?

The degree of CYP3A4 dependence varies between targeted therapies, so the specific level of risk is not identical for every drug. However, the precaution is consistent across the class: NSAIDs carry interaction and bleeding risks that are relevant regardless of which targeted therapy you are on. Working out exactly where your drug sits on this spectrum is not something you need to do yourself — your oncologist knows and can tell you which painkillers are acceptable for your specific treatment.

Call now Book free consultation